BACKGROUND: Severe fatigue is a common and distressing symptom affecting approximately one in four survivors of breast cancer. The current study examined the efficacy of Internet-based cognitive behavioral therapy (ICBT) for severe fatigue in survivors of breast cancer compared with care as usual (CAU). METHODS: The authors conducted a parallel-group randomized controlled trial. Severely fatigued, disease-free survivors of breast cancer who had completed cancer treatment at least 3 months previously were eligible. Participants were randomly allocated to ICBT or CAU using computer-generated stratified block randomization. The primary outcome of fatigue severity was assessed at baseline and after 6 months, as were the secondary outcomes of functional impairment, psychological distress, and quality of life. Statistical effects were tested with analyses of covariance (intention-to-treat analysis). RESULTS: Participants were recruited between January 2014 and March 2016 and assigned to ICBT (66 patients) or CAU (66 patients). Compared with the participants who had received CAU, those who had received ICBT reported lower fatigue scores at 6 months (mean difference [D], 11.5; 95% confidence interval [95% CI], 7.7-15.3) and a large effect size (Cohen d 5 1.0), with the majority of patients (73%) demonstrating clinically significant improvement. ICBT also was found to lead to lower functional impairment (D, 297.8; 95% CI, 145.5-450.1) and psychological distress scores (D, 5.7; 95% CI,) and higher quality-of-life scores (D, 11.7; 95% CI,.7) compared with CAU, with medium to large effect sizes (Cohen d 5 0.6-0.8). CONCLUSIONS: ICBT appears to be effective in reducing severe fatigue and related symptoms and meets the current need for easy accessible and more efficient evidence-based treatment options for severely fatigued survivors of breast cancer. Cancer 2017;123:3825-34.
INTRODUCTION
Severe fatigue is a common and distressing symptom that is reported by approximately one in four of survivors of breast cancer. 1 Severely fatigued survivors report a lower quality of life (QOL) and more functional impairment compared with survivors without severe fatigue. 2 Given these serious consequences, it is important to treat severe fatigue effectively. However, having evaluated the current management of cancer-related fatigue, experts recently concluded that the availability of evidence-based interventions such as graded exercise and cognitive behavioral therapy (CBT) is too limited. E-Health approaches could improve their accessibility. 3 The results of an integrative review by Post and Flanagan 4 support the feasibility and acceptability of Web-based platforms for survivors of breast cancer. The authors also evaluated the efficacy of Internet-based interventions in this patient population, and concluded that the strongest data have been provided by studies on Internet-based CBT (ICBT) interventions. 4 To our knowledge to date, the ICBT interventions that have been evaluated for survivors of breast cancer have not specifically been aimed at fatigue. However, the effects of other types of Web-based interventions aimed at fatigue in cancer survivors are promising. A randomized controlled trial (RCT) by Yun et al 5 demonstrated that a Web-based self-management education program led to greater improvements in fatigue in cancer survivors compared with care as usual (CAU). 5 In addition, explorative analyses of a feasibility RCT by Foster et al 6 demonstrated that a Web-based self-management intervention enhanced the self-efficacy of cancer survivors in managing fatigue compared with a patients with a control condition who only received an information leaflet. However, this effect was not sustained at a follow-up of 12 weeks, and no positive effect on fatigue severity was found. 6 Another type of intervention for fatigue in cancer survivors is a Web-based, mindfulness-based cognitive therapy intervention developed by Bruggeman-Everts et al. 7 The results of an uncontrolled pilot study indicated that this intervention was effective in reducing fatigue severity. 7 This intervention currently is being tested in an RCT, but to our knowledge the results have not been published to date. 8 Another relevant, ongoing RCT concerns a pilot study by Corbett et al examining an online selfmanagement intervention with CBT elements. 9 Finally, 2 RCTs by Willems et al 10 and van den Berg et al 11 demonstrated that a general Web-based self-management intervention for psychosocial adjustment in cancer survivors (without a specific focus on fatigue) led to improvements in fatigue compared with a nonactive control group, with small effect sizes (Cohen's d of 0.2 and 0.3, respectively). 10, 11 Because to the best of our knowledge an evidencebased ICBT intervention for severe fatigue in survivors of breast cancer was lacking, we translated an evidencebased, face-to-face CBT intervention into a Web-based format. A previous review of Andersson et al 12 demonstrated the potential of this translation by concluding that, if guided by a therapist, the effects of ICBT and faceto-face CBT were equivalent for a range of psychiatric and somatic disorders. 12 The efficacy of the face-to-face intervention was shown in 2 trials aimed at severe fatigue in cancer survivors with various diagnoses, with effects being maintained at a follow-up of 2 years. [13] [14] [15] Generally, the delivery of face-to-face CBT is challenging. It is an intensive intervention with a mean of 13 face-to-face sessions, 13 thereby limiting treatment capacity while being demanding for patients. ICBT makes treatment accessible to more patients because it reduces travel time and dependence on scheduled appointments with a therapist. A Web portal with information and assignments, supported by E-mail contact with a therapist, enables patients to complete the intervention online and might reduce therapist time.
The main objective of the current study was to examine whether ICBT is superior to CAU in reducing severe fatigue in survivors of breast cancer. Secondary outcomes were functional impairment, psychological distress, and quality of life (QOL). We hypothesized that ICBT would be more effective than CAU in reducing fatigue, functional impairment, and psychological distress and in improving QOL.
MATERIALS AND METHODS

Study Design and Participants
In a parallel-group multicenter RCT, we compared the efficacy of ICBT for severely fatigued survivors of breast cancer with CAU at the Radboud University Medical Center in Nijmegen, the Netherlands.
Eligible survivors of breast cancer were recruited from 8 hospitals located in the eastern and southern parts of the Netherlands using various recruitment strategies: physicians and nurses introduced the study to eligible patients during a regular follow-up consultation, nurse practitioners informed cohorts of eligible patients about the study by mail (ie, clinician-referred participants), or patients were approached by patients' associations and participating hospitals via social media such as Facebook and Twitter (ie, self-referrals). If interested, patients were invited to sign up for the study on a dedicated Web site.
All participants were enrolled by the primary researcher (H.J.G.A.). Patients who signed up for participation received verbal and written information regarding the study and patient questions were addressed, after which interested patients were screened for eligibility. Female patients were eligible if they were aged 18 years, free of disease, and had completed treatment for breast cancer with curative intent at least 3 months previously (barring hormone and targeted therapy) as verified by their general practitioner, oncologist, or surgeon. If potential participants were able to speak, read, and write Dutch and had access to a computer and the Internet, they were screened online for being severely fatigued (defined as a score of 35 on the Fatigue Severity subscale of the Checklist Individual Strength [CIS-Fatigue Severity]) and having basic Internet skills (eg, having an E-mail address and being able find information online). Exclusion criteria were: 1) comorbidity that could explain the severe fatigue (as assessed by a medical oncologist [C.V.]); 2) a depressive disorder (as assessed with the Beck Depression Inventory for Primary Care and, in the case of a score of 4, the Depression module of the MiniInternational Neuropsychiatric Interview); 3) undergoing current psychological treatment for a psychiatric disorder; and 4) undergoing current CBT for fatigue. At the start of the study, patients aged 65 years also were excluded. However, to increase the number of eligible patients, this maximum age restriction was lifted during the study.
After providing written informed consent, the survivors of breast cancer who were enrolled in the trial completed a baseline assessment at the study treatment center, after which they were randomized (allocation ratio of 1:1) to either the intervention condition comprising ICBT or the control condition consisting of CAU. After 6 months, participants completed the second assessment online. Further details regarding the study design have been published in a protocol article. 16 The RCT was reviewed and approved by the Arnhem-Nijmegen Medical Research Ethics Committee (NL43781.091.13) and the ethics committees of the participating hospitals. The study was recorded in the Netherlands Trial Registry (no. NTR4309).
Randomization
Randomization was in blocks of 6 and stratified based on time since cancer treatment (3-12 months vs 12 months) and type of referral (clinician-referred participants vs self-referrals). The computer-generated allocation sequence was prepared by an independent statistician, whereas a test assistant who performed the randomization informed individual participants about the allocation by telephone. The primary researcher and the test assistant were not blinded for allocation after randomization because of practical constraints. Statistical analyses were conducted by an independent researcher who was blinded for the allocation.
Intervention Condition
ICBT for severely fatigued survivors of breast cancer was developed from an evidence-based, face-to-face CBT protocol for severely fatigued cancer survivors with mixed cancer diagnoses. [13] [14] [15] The protocol is based on a cognitive behavioral model of precipitating and perpetuating factors of fatigue, in which it is assumed that the malignancy and its treatment induce the fatigue whereas cognitive behavioral factors (eg, a deregulated sleep-wake cycle or dysfunctional cognitions regarding fatigue) maintain the fatigue. 13 ICBT consisted of a total of 3 face-to-face sessions and a maximum of 8 Web-based modules. Participants initiated ICBT with 2 face-to-face sessions, after which they followed their treatment online, in which they were guided by licensed cognitive behavioral therapists through electronic consultations (ie, E-mail contacts and a maximum of 2 telephone or video consultations). Six therapists delivered the intervention, which was tailored to the individual patient. The intended duration of ICBT was 6 months and the intervention was completed with a faceto-face evaluation session.
All participants first set their treatment goals (module 1). They then worked on the fatigue-perpetuating factors that were applicable to them: 1) poor coping with breast cancer (treatment); 2) high fear of cancer recurrence; 3) dysfunctional fatigue-related cognitions; 4) a deregulated sleep-wake rhythm; 5) a deregulated activity pattern; and/or 6) negative social interactions and low social support. Each of these 6 fatigue-perpetuating factors corresponded with a treatment module (modules 2-7). Finally, participants realized their treatment goals (module 8).
The intervention was tailored to the individual patients. At baseline, it was decided which modules were relevant to them. Assessment tools were used to assess which fatigue-perpetuating factors were present and which treatment modules patients needed to follow. A detailed description of these assessment tools and cutoff scores has been provided in the protocol article. 16 
Control Condition
Participants in the control condition received CAU, which meant that they were placed on a 6-month waiting list for face-to-face CBT, which was the regular waiting time at the treatment center because of limited treatment capacity. CAU also comprised oncological follow-up examinations and a referral for psychosocial care, if pertinent. There were no restrictions regarding the use of fatigue interventions for the duration of the study, but all participants were requested to report these at 6 months.
Outcome Measures
Primary outcome
The primary outcome was fatigue severity as assessed with the 8-item CIS-Fatigue Severity (7-point Likert scale [range, ). The CIS-Fatigue Severity measures the patient's fatigue levels over the past 2 weeks, with higher scores indicating higher levels of fatigue. The cutoff score for severe fatigue is 35. 17 Previous studies have shown the reliability and validity of the subscale to be good to excellent. [17] [18] [19] It has been used before in intervention studies with cancer survivors. 
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Evaluation of ICBT Two raters (H.J.G.A. and an independent researcher) screened a random selection of 5% of all E-mails sent by the therapists to determine treatment integrity in terms of the percentage of intervention elements that were in accordance with the treatment protocol. The percentage of scores that were rated equally by the 2 raters (interrater agreement) also was calculated.
Participants were defined as ICBT starters if they had filled in their treatment goals on the Internet portal, which was a prerequisite to gain access to the other modules. Participants were defined as treatment dropouts if they had agreed with their therapist to discontinue ICBT prematurely. Criteria to determine which modules were indicated for each patient have been reported in the protocol article. 16 The percentages of indicated modules were calculated, as well as the percentages of patients who had opened these modules.
Therapists recorded the time they spent on each patient during ICBT. At 6 months, all ICBT completers rated their satisfaction with ICBT on a scale of 1 to 10, with 10 being the most positive score.
Statistical Analysis
Sample size calculation A sample of 120 participants was needed for a Student t test with an a of .05, a 2-sided significance level, and a power of 0.85. 16 Based on a study that examined the efficacy of a minimal intervention for patients with medically unexplained chronic fatigue, we assumed a clinically relevant difference in fatigue severity between the intervention and control condition of 6 points. 26 To calculate the required sample size for an analysis of covariance, this sample size was multiplied with the factor (1-r 2 ), in which r was 0.36. 27 This resulted in a minimal number of 53 patients in each condition. Because we expected treatment dropout to be 50% higher than the rate recorded in the 2006 RCT examining the efficacy of face-to-face CBT (13%) because of decreased therapist involvement, we included a dropout margin of 19.5% in the sample size calculation. 13, 16 This resulted in a sample size of 132 participants.
Statistical effects
Descriptive statistics, chi-square tests, and independentsample Student t tests were used to confirm the comparability of the baseline characteristics of the intervention and control groups. Analyses of covariance were conducted to assess the efficacy of ICBT on fatigue severity, functional impairment, psychological distress, and QOL compared with CAU. Condition was entered as the fixed factor and baseline scores on the corresponding questionnaires as the covariates. Standardized effect sizes (Cohen d) were calculated by subtracting the unadjusted mean scores of the intervention and control condition at 6 months, divided by the pooled standard deviation (SD) of both groups at 6 months. Effect sizes of 0.2 to 0.5 were considered small, those of 0.5 to 0.8 as moderate, and those 0.8 as large. 28 All analyses were based on intention to treat for all participants. SPSS statistical software (version 22; IBM Corporation, Armonk, NY) was used for all analyses.
Sensitivity analyses
We conducted multiple imputation for missing values for the primary and secondary outcomes at 6 months based on the assumption that data were missing at random, using fully conditional specification with 20 imputations. 29 A sensitivity analysis was conducted to assess the robustness of our findings for missing data. We computed whether findings would be maintained in the case of no change in missing values in the intervention condition at 6 months using the last observation carried forward. We assumed improvement in the control condition because regression toward the mean is likely to occur. 30 Because lower scores indicate more improvement, we subtracted the mean change score of the controls (ie, baseline score minus score at 6 months) from the baseline score for missing values in the CAU condition. With regard to QOL, for which higher scores indicate better functioning, we added the mean change score of the controls to the score at 6 months. In addition, we conducted a post hoc perOriginal Article protocol analysis including all ICBT completers and all participants who had not received any additional treatment for their fatigue during the trial.
Clinical significance
A clinically significant improvement was defined as a reliable change index of at least -1.96 and a fatigue level within the normal range (CIS-Fatigue Severity <35).
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In addition, participants rated improvement at 6 months using a single question to which they could respond with "I am no longer bothered by fatigue," "I feel much better," "I experience the same level of fatigue," or "the fatigue has worsened in the past 6 months," in which the first 2 response options were considered to indicate self-rated improvement. 13 We used chi-square tests to compare the percentages of clinically significant and self-rated improvement in the ICBT group with the percentages in the control group.
RESULTS
Sample Characteristics
Between January 2014 and March 2016, a total of 291 survivors of breast cancer indicated they wished to be informed about the study, of whom the primary researcher excluded 70 (24%) women, whereas 89 women (31%) declined participation. In total, 132 patients (45%) were included and randomized to ICBT (66 patients) and CAU (66 patients). Figure 1 shows the flow chart of patient inclusion, with reasons for ineligibility and nonparticipation.
The baseline characteristics of the participants are shown in Table 1 . None of these characteristics differed significantly between the 2 conditions. We recorded 2 serious adverse events during the trial. Both concerned cancer recurrence in 2 participants in the CAU condition, 1 of whom withdrew from the study. Of the 66 women assigned to ICBT, 3 (5%) did not initiate the intervention and 2 (3%) discontinued treatment prematurely (see Fig.  1 for further details). 
Efficacy of ICBT
Primary outcome
The results of the intention-to-treat analyses of the primary and secondary outcomes at 6 months are shown in Table 2 . Participants randomized to ICBT reported significantly lower fatigue scores compared with those who received CAU. The effect size was large (Cohen d 5 1.0; 95% confidence interval [95% CI], 0.6-1.3).
Secondary outcomes
Compared with the CAU patients, participants in the ICBT condition reported less functional impairment and psychological distress, and a better QOL at the 6-month assessment. Effect sizes were moderate (Cohen d of 0.6, 0.8, and 0.7, respectively).
Clinical significance
The percentage of survivors of breast cancer with clinical improvement of fatigue severity was significantly higher after ICBT (73%) than after CAU (27%), as was the case with self-rated improvement (85% in the ICBT group vs 31% in the CAU condition) ( Table 2 ). The change in fatigue scores for each individual participant is depicted in Figure 2 32 ; the figure also shows whether the change between baseline and the 6-month assessment was clinically significant and reliable or reliable only, and whether there was no change or a deterioration in fatigue. There was more often clinically significant and reliable change noted in the ICBT condition, and more often no change observed in the control condition.
Sensitivity Analyses
Scores of 2 participants (2%) in the CAU condition were missing for all outcome measures at the 6-month assessment, whereas 4 of the 132 survivors of breast cancer (3%) had only completed the primary outcome measure at 6 months. The results of the sensitivity analyses demonstrated the robustness of the findings of the current study for missing data (see Supporting Information Table S1 ).
In the per-protocol analysis, 3 ICBT nonstarters, 2 treatment dropouts, and 12 participants who received treatment for their fatigue other than ICBT during the study were excluded. The effect sizes computed for the remaining participants were higher (fatigue severity: d 5 1.2; functional impairment: d 5 0.7; psychological distress: d 5 0.9; and QOL: d 5 0.9) (see Supporting Information Table S2 ).
Evaluation of ICBT
With regard to treatment integrity, a mean of 95% of the interventions in the E-mails sent by therapists were delivered in accordance with the ICBT protocol, with an interrater agreement of 99%. The mean self-reported therapist time for ICBT completers (face-to-face sessions and electronic consultations) was 7.1 hours (SD, 2.5 hours; range, 3.6-16.6 hours). The mean duration of ICBT was 25 weeks (SD, 4 weeks). The mean number of electronic consultations was 11, with an average of 10 E-mails and 1 telephone/video consultation. Supporting Information Table S3 shows the percentages of modules that were indicated and opened during ICBT, which ranged from 63% to 100%. The vast majority of ICBT completers (85%) gave their overall satisfaction with ICBT a score of 7 of 10, with a mean score of 7.6. Original Article 32 Two patients were not included due to missing data on the CIS-Fatigue Severity subscale at baseline. The CIS-Fatigue Severity score already dropped below the cutoff score for severe fatigue (CIS-Fatigue Severity <35) between screening and baseline in 5% of participants. CAU, care as usual; ICBT, Internet-based cognitive behavioral therapy.
DISCUSSION
To our knowledge, the current study is the first RCT to examine the efficacy of an ICBT intervention specifically aimed at decreasing severe fatigue in survivors of breast cancer. Compared with participants who had received CAU, participants in the ICBT condition reported significantly less fatigue, with a large effect size and the majority demonstrating clinically significant and self-rated improvement. ICBT also was found to lead to significantly less functional impairment and psychological distress and a better QOL compared with CAU.
The Web-based intervention was based on our center's treatment protocol for face-to-face CBT for severe fatigue, the efficacy of which was demonstrated in 2 previous RCTs. 13, 14 Comparing the effect sizes, we found that both treatment formats appeared to be equally effective in reducing severe fatigue (effect size for ICBT: 1.0 [95% CI, 0.6-1.3] vs effect size for face-to-face CBT: 1.0 [95% CI, 0.6-1.5]). 13 This is in keeping with a previous metaanalysis that demonstrated that the effects of face-to-face CBT and therapist-guided ICBT also were equivalent in patients with various psychiatric and somatic disorders. 12 The effects of the current ICBT intervention on fatigue were found to be large compared with other Webbased interventions for fatigue in cancer survivors. The results of the RCT by Yun et al 5 on a Web-based selfmanagement education program demonstrated rates of clinically relevant improvement for fatigue outcomes ranging from 47% to 56% in the intervention condition and from 33% to 45% in the control condition. 5 In addition, the pilot study by Bruggeman-Everts et al 7 demonstrated that Web-based, mindfulness-based cognitive therapy led to a clinically relevant improvement in 35% of participants. 7 The effects of general self-management interventions on fatigue in the RCTs of Willems et al and van den Berg et al were small (Cohen's d of 0.2 and 0.3, respectively) compared with the current study. 10, 11 In the current study, approximately 73% of patients demonstrated clinically significant improvement regarding fatigue compared with 28% of patients in the CAU condition, and the Cohen's d effect size of 1.0 was large. These positive findings may be explained in part by the fact that the intervention was based on an evidence-based face-to-face protocol, and guided by experienced therapists who worked at a specialized tertiary treatment center.
Although ICBT seems to be a relatively more effective intervention, it should be determined whether the efficiency of the intervention can be improved. The mean duration of the intervention of 24 weeks is long compared with other Web-based interventions for fatigue. For example, the duration of the Web-based self-management education program of Yun et al was 9 weeks, 5 and the Web-based, mindfulness-based cognitive therapy intervention of Bruggeman-Everts et al took 12 weeks. 7 In future research, it should be examined whether the duration of ICBT can be shortened without losing efficacy. In addition, ways to decrease therapist involvement need to be examined to further improve treatment capacity. Integration of computerized automated feedback into the intervention could be useful to realize this objective.
Not all indicated modules were opened by patients who followed ICBT. Therapists guided patients through the Web site by E-mail, and suggested which modules patients should read. However, this was only suggested as advice, and none of the modules were stated to be mandatory to follow. In addition, patients had access to optional modules that were not indicated for them. This made it difficult to define proper adherence criteria. We had predicted that minimal therapist involvement would lead to more participants dropping out of ICBT (an estimated 20%) than generally is the case for face-to-face interventions. Surprisingly, only 8% of patients discontinued ICBT prematurely.
The expectation that less therapist involvement is required for ICBT appears to be confirmed by the results of the current study: the mean therapist time per participant was 7.1 hours (range, 3.6-16.6 hours) for ICBT compared with 12.5 hours (range, 5-26 hours) 13 in faceto-face CBT. Although the results of the current study suggest that ICBT is more time-efficient, a note of caution is in order because the 2 treatment formats, although based on the same protocol, were studied in different patient samples.
In the current study protocol, we planned to determine whether ICBT already could be provided from 3 months (instead of the regular 12 months) after cancer treatment. We wanted to compare the efficacy of ICBT between patients who had completed cancer treatment 3 to 12 months previously with those who had completed treatment >12 months previously. However, conclusions could not be drawn because the current analysis was underpowered (only 23% of participants fell into the first category).
Limitations of the current study are a lack of blinding of the outcome assessors (due to practical constraints) and a lack of an active control condition. The clinically significant improvement in fatigue noted in 28% of the survivors in the control condition is remarkable because cancer-related fatigue generally is considered to be a Original Article persistent symptom. Assuming that in some of these survivors the fatigue had been transitory, it would be better to offer the intervention only to those patients with chronic fatigue symptoms (ie, those indicating a duration of persistent fatigue of at least 6 months) to avoid patients being treated unnecessarily. Another limitation of the current study concerns the fact that we could not determine the long-term effect of ICBT. Controlled follow-up assessments could not be incorporated into the design of the current study because patients in the CAU condition were placed on a waiting list to receive face-to-face CBT directly after the 6-month assessment.
Given the limited budgets in mental health care, future studies need to determine the cost-effectiveness of ICBT. 33 We propose that combining our ICBT program for cancer-related fatigue with a stepped-care model is likely to further increase treatment efficiency. Toward this end, we will extend the current study to a noninferiority trial (Dutch Trial Registry trial no. NTR5179), in which survivors of breast cancer will be offered face-to-face sessions in addition to ICBT, if possible. Outcomes again will be compared with usual care (ie, face-to-face CBT after a 6-month waiting period). If the Web-based, stepped-care intervention is not found to be inferior to usual care, broader implementation will be considered.
It also should be noted that with a mean age of 51.5 years, the participants in the current study were relatively young, whereas breast cancer is most prevalent among women aged 60 to 75 years. 34 This limits the generalizability of the current study results and may indicate that ICBT in particular attracts younger women, but we must not overlook those severely fatigued survivors of breast cancer whose Internet literacy skills are deficient or who reject online interventions. It is important that face-toface CBT remains available for these women. Moreover, the current study should be replicated among cancer survivors with different tumor types because we are unsure whether the results of the current study can be generalized to these patient populations.
Requiring less therapist involvement than face-toface CBT without losing efficacy, ICBT appears to be a logical next step in the development of more accessible, minimally intensive psychological interventions for severely fatigued survivors of breast cancer.
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